Studies have shown that CD3EAP affects the transcription process of rRNA, RNA polymerase activity, and cell proliferation; CD3EAP can also mediate the activation pathway of T cells to produce leukocyte interleukin-2 to inhibit the growth of cancer cells (Lovci et al., 2016; Wang et al., 2019). Here, POLR1G is linked to cancer.